Hacène Khiri Selected Research

Hacène Khiri Research Topics

7	Infections 01/2022 - 02/2006
2	Uterine Cervical Dysplasia 12/2018 - 01/2010
2	Chronic Hepatitis C 02/2006 - 12/2005
1	COVID-19 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2018
1	Hepatitis C 01/2018
1	Neoplasms (Cancer) 01/2017
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2017
1	Viremia 01/2017
1	Chronic Hepatitis (Chronic Active Hepatitis) 12/2013
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 05/2010
1	Atypical Squamous Cells of the Cervix 02/2007
1	Virus Diseases (Viral Diseases) 02/2006
1	Coinfection 01/2006

4	RNA (Ribonucleic Acid)IBA 05/2010 - 01/2006
3	DNA (Deoxyribonucleic Acid)IBA 12/2013 - 02/2007
2	Antiviral Agents (Antivirals)IBA 01/2018 - 02/2006
2	InterferonsIBA 12/2013 - 12/2005
1	SolutionsIBA 01/2022
1	AntigensIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 12/2018
1	Messenger RNA (mRNA)IBA 12/2018
1	Integrase InhibitorsIBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017
1	Hepatitis B e AntigensIBA 12/2013
1	NucleotidesIBA 12/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2013
1	InterleukinsIBA 01/2012
1	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link 01/2010
1	Virus-Like Particle VaccinesIBA 01/2010
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2008
1	HomocysteineIBA 04/2008
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2008
1	Viral RNAIBA 01/2006

2	Therapeutics 02/2006 - 12/2005
1	Retreatment 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 01/2017